OAOzgur Artunay

Ozgur Artunay

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ozgur Artunay has a total of 102 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Incidence and visual outcomes of post-intravitreal injection endophthalmitis: a single-centre analysis of 224,397 injections

    by Gulce Kayikci Mahmutoglu, Metehan Simsek, Sadik Gorkem Cevik, Murat Arici, Anil Korkmaz, Mediha Tok Cevik, Ozgur Artunay

    Post-injection endophthalmitis (PIE) is a rare, vision-threatening complication of intravitreal injections (IVIs). As IVI volumes rise globally, optimising prevention and management is crucial. This study evaluated PIE incidence, risk factors, microbiology, and outcomes over ten years. A retrospective cohort study of 224,397 IVIs. We analysed demographics, agent type, and preparation (pre-filled syringe [PFS] vs. manual aliquoting). Overall endophthalmitis incidence was 0.029% (n = 65), and 0.026% for anti-VEGFs. PFS-ranibizumab had the lowest incidence (0.014%) and was significantly safer than manually prepared bevacizumab (0.039%; OR: 2.74 [95% CI: 1.36-5.55], p = 0.003); vial-sourced aflibercept (0.027%) was intermediate and not statistically distinguishable from either. Culture positivity was 33.8% (n = 22), predominantly Gram-positive (81.8%), with Staphylococcus epidermidis being the most common (45.5%). In univariate analysis, culture positivity was the sole predictor of worse final visual acuity (VA) (p = 0.030), though limited by small sample sizes. Median VA worsened from 0.61 logMAR at baseline to 2.10 logMAR at presentation, recovering to 1.80 logMAR at final visit (p < 0.001). Among cases initially treated with tap and intravitreal antibiotics (TAI), 60% (21/35) required subsequent vitrectomy (PPV). No baseline clinical parameters predicted TAI success or PPV requirement (all p > 0.05). Dexamethasone implants, with their larger applicator, carried the highest risk. Among anti-VEGFs, PFS ranibizumab demonstrated the most favourable safety profile, with the lowest incidence of PIE. Manual immediate-use bevacizumab aliquoting is a safe, cost-effective alternative in resource-limited settings. In univariate analysis, culture positivity emerged as a negative prognostic factor, though this finding is limited by small sample sizes. Given unpredictable TAI responses, aggressive monitoring and a low PPV threshold are essential.

  • Ab Externo Transscleral Removal of Submacular Proliferative Bands in Pediatric Rhegmatogenous Retinal Detachment with PVR: A Surgical Technique Case Series

    by Ozgur Artunay, Sehnaz Ozcaliskan, Merve Ozbek, Ceren Gurez, Abdullah Ağın

    Purpose: To describe an ab externo surgical technique for submacular band removal in pediatric patients with rhegmatogenous retinal detachment (RRD) complicated by proliferative vitreoretinopathy (PVR). Methods: Ten eyes of 10 pediatric patients diagnosed with RRD and PVR grade C associated with submacular bands. All eyes underwent submacular band removal using an ab externo transscleral approach combined with scleral buckling and 23-gauge pars plana vitrectomy. Preoperative localization of submacular bands was performed using optical coherence tomography and/or B-scan ultrasonography, with intraoperative targeting guided by Resight viewing. Results: Submacular band removal via the ab externo approach was successfully performed in all 10 eyes. The mean patient age was 10.8 ± 3.2 years (range, 5–16 years). Preoperative hypotony (intraocular pressure <6 mmHg) was present in three eyes. Postoperatively, visual acuity improved in four patients, remained stable in four, and worsened in two. No cases of postoperative epiretinal membrane formation or significant subretinal hemorrhage were observed. Retinal reattachment was achieved in 9 of 10 eyes (90%), while one eye progressed to pre-phthisis. Conclusions: Ab externo submacular band removal appears to be a useful adjunct to pars plana vitrectomy in selected pediatric RRD cases with PVR, allowing relief of submacular traction without the need for retinotomy.

  • Open Access

    Intravitreal Faricimab for Retinal Vein Occlusion: Real-World Outcomes from the Multicenter FARTURK-RVO Study in Türkiye

    by Fevzi Akkan, Ebru Görgün, Burak Erden, Yavuz Kamil Bardak, Nigar Şerif, Mahmut Öztürk, Erkan Çelik, Selim Bölükbaşı, Şefik Can İpEk, Tahsin Uzundede, et al.

    The aim of this study was to evaluate the real-world efficacy and safety of intravitreal faricimab for macular edema (ME) secondary to retinal vein occlusion (RVO) across a multicenter cohort with up to 52 weeks of follow-up. Data from 17 centers across Türkiye were retrospectively analyzed between 22 November 2024 and 1 March 2026. Patients with branch RVO (BRVO) or central RVO (CRVO) complicated by ME who received at least one intravitreal faricimab injection and had complete ophthalmic and optical coherence tomography (OCT) data with a minimum 4-week follow-up were included. Demographics, diagnosis, prior treatments, best-corrected visual acuity (BCVA; decimal converted to logMAR), central macular thickness (CMT), intraocular pressure (IOP), injection number, follow-up duration, and ocular/systemic adverse events were recorded at baseline, day 7, monthly after each of the first three injections, and at the final visit. A total of 70 patients (37 BRVO [52.9%], 33 CRVO [47.1%]) were included, with a mean follow-up of 23.69 ± 8.54 weeks; 44 (62.8%) were treatment-naïve and 26 (37.2%) were switch patients. When comparing baseline and final visits, treatment-naïve patients showed a mean CMT reduction of 306.9 ± 231.3 µm (from 594.1 ± 206.9 µm at baseline to 287.2 ± 89.9 µm at final visit; p < 0.001), while switch patients demonstrated a mean CMT reduction of 290.6 ± 114.3 µm (from 562.1 ± 107.3 to 271.5 ± 90.7 µm; p < 0.001). The mean logMAR BCVA gain was 0.77 (p < 0.001) in naïve and 0.38 (p < 0.001) in switch patients. IOP remained stable throughout, and no serious ocular or systemic adverse events were recorded. Faricimab demonstrated rapid anatomical and functional improvements in the RVO cohort, evident as early as day 7 after the initial injection. These findings support faricimab as a potent and reliable therapeutic option across both RVO subtypes in routine clinical practice.

  • CLINICAL AND IMAGING PREDICTORS OF BILATERAL INVOLVEMENT IN CENTRAL SEROUS CHORIORETINOPATHY

    by Oyku Okur, Metehan Simsek, Merve Ozbek, Sadık Görkem Çevik, Ozgur Artunay

    Purpose: This research investigated the risk factors and multimodal imaging characteristics associated with the onset of central serous chorioretinopathy (CSCR) in the contralateral eye during follow-up of patients initially presenting with unilateral complex CSCR. Methods: In this retrospective cohort, patients observed between 2015 and 2023 were classified into two groups: those progressing from unilateral to bilateral CSCR formed the study group, whereas patients who did not develop contralateral disease during follow-up comprised the control group. Demographic characteristics and smoking status were recorded. Multimodal imaging was documented. Results: A total of 126 eyes from 63 patients were evaluated, including 31 with bilateral disease (Group 1) and 32 with unilateral CSCR (Group 2). In Group 1, the mean interval between involvement of the first and second eye was 21.29 ± 18.46 months. At baseline, the mean subfoveal choroidal thickness in affected eyes was 293 ± 67 µ m in the study group, significantly lower than the 356 ± 64 µ m observed in controls ( P < 0.001). Multivariate regression analysis demonstrated that smoking, the presence of CSCR-related changes in the fellow eye on initial fundus fluorescein angiography (FFA), and reduced choroidal thickness in the first affected eye were independent predictors of bilateral disease progression. Conclusion: The findings indicate that smoking, early CSCR-related changes in the contralateral eye on baseline FFA, and reduced choroidal thickness in the initially affected eye represent significant risk factors for bilateral CSCR development.

  • Retinal displacement after retinal detachment surgery: Comparative analysis of vitrectomy, scleral buckling, and pneumatic retinopexy

    by Sadik Gorkem Cevik, Gulce Kayikci Mahmutoglu, Metehan Simsek, Sehnaz Ozcaliskan, Merve Ozbek, Anıl Korkmaz, Murat Arici, Ozgur Artunay

    Purpose: To evaluate the incidence of postoperative retinal displacement (RD) following three surgical techniques—pars plana vitrectomy (PPV), scleral buckling (SB), and pneumatic retinopexy (PR)—for macula-off rhegmatogenous retinal detachment (RRD). Methods: In this retrospective observational study, 183 eyes with primary macula-off RRD were treated between June 2021 and June 2023 at a tertiary care retina center. Patients underwent one of three surgical techniques: PPV, SB, or PR. RD was assessed using fundus autofluorescence imaging and correlated with early face-down positioning (EFP) and other clinical variables. Results: RD incidence varied by technique: 36.3% after PPV, 21.2% after SB, and 8.1% after PR. In PPV cases, gas tamponade was associated with higher RD rates than silicone oil (68.4% vs. 29.8%, p = 0.010), and perfluorocarbon liquid (PFCL) use was associated with increased RD (44.1% vs. 0%, p = 0.009). Adherence to EFP had no significant protective effect ( p = 0.985). Metamorphopsia was more frequent in patients with RD ( p = 0.040); final visual acuity was similar across groups. Conclusions: RD is most common after PPV and least frequent after PR. Surgical choices, particularly tamponade type and PFCL use, significantly influence RD risk and should guide surgical planning.

  • Membrane frizzled-related protein: a comprehensive analysis of genetic characteristics, phenotypic manifestations and impact on retinal microvasculature

    by Metehan Simsek, Merve Ozbek, Selim Ayata, Oguzhan Yarali, Yusuf Alperen Yarali, Ozgur Artunay

    To assess the ocular characteristics, retinal microvasculature, and long-term outcomes of patients with nanophthalmos associated with mutations in the membrane frizzled-related protein (MFRP) gene, and to compare these findings with those observed in nanophthalmos cases without MFRP gene mutations. In this retrospective cohort study, patients with MFRP-associated nanophthalmos and those with nanophthalmos without MFRP gene mutations were included. Best-corrected visual acuity (BCVA), spherical equivalent (SE), axial length (AL), optical coherence tomography (OCT), and OCT angiography parameters-including vascular density (VD) and foveal avascular zone (FAZ) measurements in the superficial capillary plexus (SCP), deep capillary plexus (DCP), and choriocapillaris (CC)-were evaluated at presentation and at the 5th-year follow-up. At presentation and 5-year follow-up, patients with MFRP-associated nanophthalmos exhibited significantly shorter AL and higher SE compared to those without MFRP mutations (all p < 0.001). Central macular thickness (CMT), subfoveal choroidal thickness (SFCT), and retinal nerve fiber layer (RNFL) thickness were significantly greater in the MFRP-associated group at presentation and 5-year follow-up (all p < 0.05). OCT angiography revealed reduced parafoveal VD in the SCP and DCP, as well as decreased foveal and parafoveal VD in the CC in the MFRP group compared to the group without MFRP mutations (all p < 0.05). FAZ areas in the SCP and DCP were also significantly smaller in the MFRP group (p < 0.001 and p = 0.01, respectively). Eyes with MFRP-associated nanophthalmos exhibit significantly higher SE, shorter AL, and more pronounced alterations in retinal structure and microvasculature compared with eyes without MFRP mutations.


  • Open Access

    Macular Telangiectasia Type 2: Long-Term Disease Progression and Management of Complications

    by Merve Özbek, Özgür Artunay, Rümeysa Koçak, İlker Hoşver, Metehan Şimşek

    Macular Telangiectasia Type 2: Long-Term Disease Progression and Management of Complications - Turkish Journal of Ophthalmology


  • Oxidative Stress and Inflammatory Cytokines in Vitreous and Subsilicone Fluids in Patients with Rhegmatogenous Retinal Detachment

    by Erdem Erdogdu, Sehnaz Özcaliskan, Tuna Ozan Dogan, Özgür Artunay

    To investigate the oxidative stress (OS) and inflammatory cytokine (IC) levels in vitreous and subsilicone fluid (SSF) in cases with rhegmatogenous retinal detachment (RRD). This prospective study included 21 cases of uncomplicated RRD. Total antioxidant status (TAS) and total oxidant status (TOS) in the samples were determined by automatic measurement method and IC levels were determined by ELISA method. In addition to routine ophthalmological examinations, flare, optic coherence tomography (OCT) and enhanced depth imaging-OCT measurements were performed during follow-up. There was a significant difference in the TOS and oxidative stress index (OSI) in SSF compared to vitreous (p < 0.05). IL-1β level was detected significantly higher in vitreous fluid (p = 0.004). When the correlation between TAS, TOS, OSI and cytokine levels in SSF and the difference in central macular thickness (CMT), choroidal thickness and flare changes measured in the 1st and 3rd month follow up of the cases after vitrectomy were evaluated, only negative correlation was observed between TOS, OSI, and CMT. OS, which has not been previously investigated in SSF, was significantly higher in this study, and our findings suggest that OS may have an initiating role in retinal damage thought to be caused by silicone oil.